Ocular Therapeutix reported a gross margin of 85.08% and a net margin of -589.63% for the quarter ended Jun 2026. These financial ratios cover 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 89.22% | 91.00% | 90.14% | 90.58% | 91.03% | 92.81% | 90.92% | 91.41% | 90.87% | 90.64% | 91.02% | 90.82% | 89.88% | 92.80% | 88.20% | 85.56% | 87.80% | 87.97% | 87.68% | 85.08% | |||||||||||||||||||||||||||||||||
| EBT Margin | -174.28% | -160.25% | -147.86% | -175.60% | -192.70% | -147.67% | -177.61% | -143.64% | -142.09% | -153.65% | -214.88% | -247.86% | -282.46% | -286.92% | -589.60% | -499.31% | -467.35% | -492.45% | -835.11% | -589.63% | |||||||||||||||||||||||||||||||||
| EBIT Margin | -160.69% | -146.64% | -135.23% | -162.37% | -180.06% | -137.56% | -168.60% | -135.45% | -127.41% | -135.46% | -214.00% | -265.13% | -298.20% | -296.08% | -597.47% | -502.57% | -472.35% | -526.49% | -865.46% | -609.34% | |||||||||||||||||||||||||||||||||
| EBITDA Margin | -160.69% | -146.64% | -135.23% | -162.37% | -180.06% | -137.56% | -168.60% | -135.45% | -127.41% | -135.46% | -214.00% | -265.13% | -298.20% | -296.08% | -597.47% | -502.57% | -472.35% | -526.49% | -865.46% | -609.34% | |||||||||||||||||||||||||||||||||
| Operating Margin | -160.69% | -146.64% | -135.23% | -162.37% | -180.06% | -137.56% | -168.60% | -135.45% | -127.41% | -135.46% | -214.00% | -265.13% | -298.20% | -296.08% | -597.47% | -502.57% | -472.35% | -526.49% | -865.46% | -609.34% | |||||||||||||||||||||||||||||||||
| Net Margin | -174.28% | -160.25% | -147.86% | -175.60% | -192.70% | -147.67% | -177.61% | -143.64% | -142.09% | -153.65% | -214.88% | -247.86% | -282.46% | -286.92% | -589.60% | -499.31% | -467.35% | -492.45% | -835.11% | -589.63% | |||||||||||||||||||||||||||||||||
| FCF Margin | -109.09% | -128.24% | -143.14% | -92.70% | -116.70% | -135.76% | -174.61% | -145.30% | -52.99% | -154.81% | -232.02% | -154.53% | -237.59% | -232.00% | -435.63% | -419.67% | -389.98% | -430.85% | -655.12% | -524.22% | |||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.17M | 1.24M | 1.30M | 1.43M | 1.52M | 1.76M | 2.12M | 2.23M | 2.23M | 2.28M | 2.44M | 2.56M | 2.48M | 2.72M | 3.15M | 3.15M | 3.26M | 3.53M | 3.65M | 3.78M | |||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 224.22M | 211.31M | 196.25M | 180.35M | 165.82M | 153.93M | 138.93M | 125.57M | 142.47M | 207.22M | 395.50M | 528.02M | 503.73M | 474.15M | 431.93M | 428.63M | 431.11M | 609.47M | 770.29M | 701.92M | |||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 112.28M | 113.00M | 104.86M | 90.93M | 71.42M | 60.64M | 35.03M | 28.47M | 72.98M | 156.92M | 474.44M | 467.13M | 419.84M | 383.85M | 335.13M | 375.82M | 328.85M | 725.65M | 653.64M | 592.84M | |||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.17 | 0.21 | 0.25 | 0.28 | 0.30 | 0.33 | 0.37 | 0.43 | 0.41 | 0.28 | 0.15 | 0.12 | 0.12 | 0.13 | 0.14 | 0.13 | 0.13 | 0.09 | 0.07 | 0.07 | |||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -11.78 | -10.74 | -10.60 | -11.74 | -11.99 | -10.48 | -12.75 | -10.33 | -5.61 | -4.83 | -7.80 | -13.64 | -14.27 | -16.28 | -21.42 | -22.43 | -22.88 | -24.63 | -33.61 | -29.41 | |||||||||||||||||||||||||||||||||
| Debt Ratio | 0.11 | 0.12 | 0.13 | 0.15 | 0.16 | 0.17 | 0.20 | 0.21 | 0.40 | 0.26 | 0.12 | 0.13 | 0.14 | 0.15 | 0.17 | 0.15 | 0.17 | 0.09 | 0.10 | 0.11 | |||||||||||||||||||||||||||||||||
| Times Interest Earned | -11.78 | -10.74 | -10.60 | -11.74 | -11.99 | -10.48 | -12.75 | -10.33 | -5.61 | -4.83 | -7.80 | -13.64 | -14.27 | -16.28 | -21.42 | -22.43 | -22.88 | -24.63 | -33.61 | -29.41 | |||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -36.17 | -27.12 | -19.49 | -14.35 | -13.86 | -10.44 | -17.20 | -18.74 | -11.64 | -15.66 | -44.35 | -26.12 | -31.28 | -27.49 | -18.51 | -23.88 | -30.09 | -40.17 | -20.59 | -27.14 | |||||||||||||||||||||||||||||||||
| Price to SalesP/S | 63.04 | 43.45 | 28.81 | 25.21 | 26.71 | 15.41 | 30.55 | 26.92 | 16.53 | 24.05 | 95.29 | 64.74 | 88.36 | 78.87 | 109.12 | 119.23 | 140.62 | 197.84 | 171.91 | 160.03 | |||||||||||||||||||||||||||||||||
| Price to BookP/B | 8.77 | 6.08 | 4.76 | 4.70 | 6.91 | 6.13 | 42.07 | 132.44 | 31.75 | 3.91 | 3.45 | 2.66 | 3.87 | 4.27 | 4.39 | 5.25 | 7.92 | 4.01 | 3.19 | 4.15 | |||||||||||||||||||||||||||||||||
| Enterprise Value | 586.79M | 370.66M | 234.54M | 174.64M | 198.64M | 114.64M | 329.49M | 342.24M | 138.80M | 160.07M | 924.77M | 604.78M | 935.68M | 955.08M | 817.71M | 1,213.61M | 1,700.39M | 1,884.30M | 1,187.36M | 1,557.73M | |||||||||||||||||||||||||||||||||
| EV to EBIT | -30.05 | -20.54 | -13.15 | -8.77 | -9.22 | -5.92 | -14.61 | -16.64 | -7.22 | -7.98 | -29.25 | -13.87 | -20.34 | -18.88 | -12.79 | -17.94 | -24.75 | -27.01 | -12.72 | -18.97 | |||||||||||||||||||||||||||||||||
| EV to EBITDA | -30.05 | -20.54 | -13.15 | -8.77 | -9.22 | -5.92 | -14.61 | -16.64 | -7.22 | -7.98 | -29.25 | -13.87 | -20.34 | -18.88 | -12.79 | -17.94 | -24.75 | -27.01 | -12.72 | -18.97 | |||||||||||||||||||||||||||||||||
| Market Capitalization | 766.07M | 534.82M | 379.96M | 309.18M | 319.59M | 216.94M | 408.51M | 408.85M | 249.35M | 356.03M | 1,407.81M | 1,064.47M | 1,362.90M | 1,347.18M | 1,167.39M | 1,604.75M | 2,045.16M | 2,621.36M | 1,854.06M | 2,156.37M | |||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -57.78 | -33.88 | -20.13 | -27.19 | -22.89 | -11.35 | -17.49 | -18.53 | -31.20 | -15.54 | -41.07 | -41.90 | -37.19 | -33.99 | -25.05 | -28.41 | -36.06 | -45.92 | -26.24 | -30.53 | |||||||||||||||||||||||||||||||||
| EV to FCF | -44.26 | -23.48 | -12.43 | -15.36 | -14.23 | -6.00 | -14.11 | -15.51 | -17.37 | -6.99 | -26.98 | -23.80 | -25.53 | -24.10 | -17.55 | -21.49 | -29.98 | -33.01 | -16.81 | -22.05 | |||||||||||||||||||||||||||||||||
| EV to CFO | -45.20 | -24.46 | -12.61 | -16.06 | -15.08 | -6.76 | -16.50 | -17.05 | -17.95 | -7.13 | -27.29 | -24.38 | -25.59 | -24.22 | -18.31 | -21.97 | -33.52 | -34.73 | -17.99 | -23.16 | |||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -160.69% | -146.64% | -135.23% | -162.37% | -180.06% | -137.56% | -168.60% | -135.45% | -127.41% | -135.46% | -214.00% | -265.13% | -298.20% | -296.08% | -597.47% | -502.57% | -472.35% | -526.49% | -865.46% | -609.34% | |||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -37.34% | -42.19% | -43.90% | -48.84% | -56.64% | -64.19% | -76.33% | -90.15% | -76.06% | -47.81% | -24.64% | -22.98% | -30.22% | -39.69% | -51.80% | -59.15% | -65.69% | -48.33% | -41.44% | -48.09% | |||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -36.13% | -40.07% | -41.92% | -45.43% | -50.54% | -55.14% | -64.16% | -71.20% | -61.61% | -43.30% | -24.71% | -22.10% | -27.56% | -34.81% | -45.47% | -51.99% | -57.35% | -43.23% | -37.71% | -43.13% |